Virios Therapeutics, Inc.
VIRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,349,724 | -$5,296 | -$12,248 | -$15,960 |
| Dep. & Amort. | $70,609 | $0 | $0 | $0 |
| Deferred Tax | -$503 | $0 | $0 | $0 |
| Stock-Based Comp. | $476,021 | $620 | $583 | $323 |
| Change in WC | $0 | -$194 | $197 | -$52 |
| Other Non-Cash | $3,012,792 | $0 | $363 | $53 |
| Operating Cash Flow | -$8,790,805 | -$4,870 | -$11,468 | -$15,690 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,761,936 | $0 | $0 | $0 |
| Investing Cash Flow | $3,761,936 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,382,170 | $1,156 | $4,491 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$295 |
| Dividends Paid | -$514,105 | $0 | $0 | $0 |
| Other Fin. Act. | $17,218,569 | $0 | $0 | $198 |
| Financing Cash Flow | $16,704,464 | $1,156 | $4,491 | -$98 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11,531,003 | -$3,714 | -$6,977 | -$15,787 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,316,946 | $7,031 | $14,008 | $29,795 |
| End Cash | $14,847,949 | $3,317 | $7,031 | $14,008 |
| Free Cash Flow | -$8,790,805 | -$4,870 | -$11,468 | -$15,690 |